CFDE Data Portal | Search MIR641

	Label	Description
	MIR641 associations Collection (Entity type)	Associations for MIR641_associations
	MIR641 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MIR641 Gene (Entity type)	ENSG00000207631 - microRNA 641
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR641 associations

Associations for MIR641_associations

MIR641 associations.tsv

A file from IDG as part of the Harmonizome project

MIR641

ENSG00000207631 - microRNA 641

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 1 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 5 human dn

A Gene Set from LINCS

GSE239844 crizotinib 8 v 10 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE239844 crizotinib 6 v 10 human up

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.